ClarityCare Backs Prior Authorization Automation as CMS Deadlines Tighten
ClarityCare has raised $16.5 million in Series A funding to expand software designed to move prior authorization decisions through health plan workflows faster. The San Francisco startup says the oversubscribed round will support sales, engineering, new product development, and a broader push into healthcare markets, especially government programs.
The financing arrives at a moment when payers are under real operational strain. A January 2026 CMS rule, CMS-0057-F, set new requirements for electronic health information exchange and gave health plans until January 1, 2027 to comply. Under the rule, expedited prior authorization decisions must be made within 72 hours, while standard requests must be resolved within seven days. Those timelines compress a process that has long relied on manual record gathering, policy checks, and paper-heavy review cycles.
One sentence captures the pressure point: many prior authorization queues were built for delay, not deadline-driven medicine.
ClarityCare is trying to solve that bottleneck with Electra, an AI agent that is built to streamline the administrative work around prior authorization. The company says the system can approve and escalate requests, but will never issue denials. Human clinicians remain in the loop for review and decision-making, which matters because the workflow is not a single task but a chain of steps that can stall at multiple points. Records have to be assembled, clinical review has to be completed, and the case then has to be closed with the right paperwork and communication.
Hermine Tranie, ClarityCare’s chief executive, said Medicaid and Medicare Advantage plans are facing the heaviest pressure from the federal rules, while commercial plans remain an important part of the company’s business. Her comments reflect a broader reality in utilization management: government-backed coverage programs often operate with high volume, tightly managed benefits, and substantial administrative overhead. When staffing is limited, every handoff adds friction.
The American Medical Association has repeatedly argued that prior authorization absorbs an outsized amount of staff time and can delay care. The association has described the process as overused, costly, inefficient, opaque, and responsible for patient care delays, while calling for more automation. ClarityCare’s pitch aligns with that critique, but its product is trying to do more than summarize charts or auto-approve straightforward codes. Tranie said existing tools tend to solve only one slice of the problem. Some rule-based systems clear simple procedure codes. Others condense records after someone has already collected them. Electra is meant to connect the entire sequence.
Why the Workflow Still Breaks Down
The technical argument is straightforward. Prior authorization fails when the administrative burden is fragmented across systems, staff roles, and decision stages. A clinician may be waiting on incomplete documentation, while a reviewer is waiting on a summary, while an operations team is waiting on final paperwork. AI can reduce the idle time between those steps if it reliably gathers, organizes, and routes information without creating a new layer of noise.
ClarityCare says its platform uses a human-in-the-loop model to reduce the risk of erroneous decisions. The software can help strengthen the clinician’s review with summaries, recommendations, and drafted communications, but it does not remove the clinician from the final judgment. In practice, that design choice reflects the clinical and legal sensitivity of prior authorization. A treatment recommendation may be routine in one plan and restricted in another. The stakes are not abstract; a delay can push back imaging, procedures, infusions, or follow-up care.
Electra is already being used by seven customers, including health plans, third-party administrators, medical management companies, and government health services organizations supporting Medicaid and Medicare programs. Those customers are located across the country. The company says its current reach affects workflows tied to care for 6 million people.
One customer has already seen a sharp reduction in wait times, with prior authorization turnaround falling from 12 days to two. Even without broader clinical outcome data, the operational signal is hard to ignore. A drop of that size suggests the bottleneck was not only clinical review capacity but the coordination work surrounding it. In prior authorization, shaving days from the process can change whether a patient waits at home, reschedules a procedure, or enters treatment on time.
Medicare and Medicaid Plans Face the Tightest Operational Squeeze
ClarityCare’s market focus makes sense given the CMS timeline. Medicare Advantage and Medicaid plans must adapt to the new federal deadlines while preserving documentation quality and compliance. The rule does not simply demand faster decisions; it also pushes electronic exchange standards that can reduce reliance on manual transmission of records. Plans that cannot move data quickly enough may struggle to meet the turnaround windows even if clinical reviewers are available.
The company’s strategy also reflects where the pain lives inside health systems and payer organizations. Prior authorization is not one job. It is an accumulation of small, repetitive tasks that consume time and attention. That is why automation can be useful only if it handles the full sequence rather than isolated fragments. A better summary alone does not solve the queue. A faster auto-approval engine alone does not help if the chart is incomplete. A polished communication draft alone does not close the case.
ClarityCare now has $19.8 million in total funding, and the new capital gives the company room to push deeper into a market that is being reshaped by regulation as much as by technology. The next test is whether its workflow automation can hold up outside the early customer base and across the messy realities of payer operations, where policy variation, documentation gaps, and staffing constraints still determine how quickly care gets approved.